about
Pre-targeting and direct immunotargeting of liposomal drug carriers to ovarian carcinomaSpecific inhibition of SRC kinase impairs malignant glioma growth in vitro and in vivo.Clinical trials for glioblastoma multiforme using adenoviral vectors.Adenovirus mediated herpes simplex virus-thymidine kinase/ganciclovir gene therapy for resectable malignant glioma.Future prospects and challenges of antiangiogenic cancer gene therapy.Requirements for baculoviruses for clinical gene therapy applications.Soluble vascular endothelial growth factor receptor-1 improves therapeutic efficacy of suicide gene therapy in an angiogenesis-independent manner.Oxidative stress-regulated lentiviral TK/GCV gene therapy for lung cancer treatment.Targeted delivery via avidin fusion protein: intracellular fate of biotinylated doxorubicin derivative and cellular uptake kinetics and biodistribution of biotinylated liposomes.A laboratory-scale device for the straightforward production of uniform, small sized cell microcapsules with long-term cell viability.Oncolytic Semliki forest virus vector as a novel candidate against unresectable osteosarcoma.Replication competent Semliki Forest virus prolongs survival in experimental lung cancer.Evaluation of cancer virotherapy with attenuated replicative Semliki forest virus in different rodent tumor models.Transcriptional targeting of virus-mediated gene transfer by the human hexokinase II promoter.
P50
Q28481572-ED0D158F-6B34-44BE-897A-CF0AF5357D2EQ36077844-1740259A-2866-4E63-8C6F-C01DA7E13782Q37608985-DA7D35AE-B51D-4249-A932-D2AC5CD5CF3CQ37622291-3CF21C5D-D870-4611-A1CF-ADBE569E0420Q37693907-F9E0CBB9-0EB7-4F7C-BA6A-8254385B21E0Q37904373-3443E899-B441-4506-BE20-2D797656C012Q38970709-04BD69D3-17CA-4969-8BE9-EF6333D04BC8Q39264777-0542E60B-89D5-43A7-9D81-8F3E9652B126Q39277069-97063229-754C-4470-9086-D19263E888F4Q39577186-D443383C-6B51-44FE-B992-4B32F8C1CC3AQ39929003-0DED535D-B470-45D9-BD41-C4E0C070EE8EQ39957846-A9730C3D-A567-4EE7-AA84-11AA6E258B0BQ40143926-03F84BDA-2D98-4AD9-9AB6-0A4113C372C8Q40224518-433BA26D-88ED-49E4-8C14-2B5943895792
P50
description
onderzoeker
@nl
name
Ann-Marie Määttä
@ast
Ann-Marie Määttä
@en
Ann-Marie Määttä
@es
Ann-Marie Määttä
@nl
type
label
Ann-Marie Määttä
@ast
Ann-Marie Määttä
@en
Ann-Marie Määttä
@es
Ann-Marie Määttä
@nl
prefLabel
Ann-Marie Määttä
@ast
Ann-Marie Määttä
@en
Ann-Marie Määttä
@es
Ann-Marie Määttä
@nl